Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.
about
Actual impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence.Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases
P2860
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Most intended management changes after
@nl
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.
@en
type
label
Most intended management changes after
@nl
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.
@en
prefLabel
Most intended management changes after
@nl
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.
@en
P2093
P2860
P1476
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.
@en
P2093
Andrew E Hendifar
Andrew Quon
Anthony P Heaney
Christiaan Schiepers
Edward M Wolin
J Randolph Hecht
Jeannine Gartmann
Jeremie Calais
Johannes Czernin
Joseph R Pisegna
P2860
P304
P356
10.2967/JNUMED.117.192450
P407
P577
2017-05-04T00:00:00Z